UNITED CAPITAL FINANCIAL ADVISORS, LLC - AMPIO PHARMACEUTICALS INC ownership

AMPIO PHARMACEUTICALS INC's ticker is AMPE and the CUSIP is 03209T109. A total of 82 filers reported holding AMPIO PHARMACEUTICALS INC in Q2 2019. The put-call ratio across all filers is 0.02 and the average weighting 0.0%.

Quarter-by-quarter ownership
UNITED CAPITAL FINANCIAL ADVISORS, LLC ownership history of AMPIO PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2022$5,000
-61.5%
76,0000.0%0.00%
Q2 2022$13,000
-56.7%
76,000
+20.6%
0.00%
Q1 2022$30,000
-6.2%
63,001
+10.5%
0.00%
Q4 2021$32,000
-66.3%
57,0000.0%0.00%
Q3 2021$95,000
+2.2%
57,000
+2.9%
0.00%
Q2 2021$93,000
-1.1%
55,4000.0%0.00%
-100.0%
Q1 2021$94,000
+8.0%
55,400
+0.7%
0.00%0.0%
Q4 2020$87,000
+64.2%
55,0000.0%0.00%
Q3 2020$53,000
+55.9%
55,000
+4.0%
0.00%
Q2 2020$34,000
+70.0%
52,890
+7.3%
0.00%
Q1 2020$20,000
-28.6%
49,301
+3.4%
0.00%
Q4 2019$28,000
+21.7%
47,698
+2.9%
0.00%
Q3 2019$23,000
+76.9%
46,368
+35.6%
0.00%
Q2 2019$13,000
-31.6%
34,1830.0%0.00%
Q1 2019$19,000
+46.2%
34,1830.0%0.00%
Q4 2018$13,0000.0%34,183
+29.3%
0.00%
Q3 2018$13,000
-74.5%
26,433
+13.9%
0.00%
Q2 2018$51,000
-26.1%
23,216
+14.3%
0.00%
-100.0%
Q1 2018$69,000
-8.0%
20,303
+9.9%
0.00%0.0%
Q4 2017$75,000
+733.3%
18,472
+21.8%
0.00%
Q3 2017$9,00015,1680.00%
Other shareholders
AMPIO PHARMACEUTICALS INC shareholders Q2 2019
NameSharesValueWeighting ↓
Shilanski & Associates, Inc. 937,237$57,0000.02%
PRIVATE CAPITAL MANAGEMENT LLC 937,237$57,0000.02%
CVA Family Office, LLC 1,137,920$69,0000.02%
Cypress Capital Management LLC (WY) 140,925$9,0000.01%
Helen Stephens Group, LLC 117,222$7,0000.01%
COURIER CAPITAL LLC 540,056$33,0000.00%
NORTHCAPE WEALTH MANAGEMENT, LLC 98,000$6,0000.00%
Newbridge Financial Services Group, Inc. 10,000$1,0000.00%
Western Wealth Management, LLC 352,950$11,0000.00%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 606,800$37,0000.00%
View complete list of AMPIO PHARMACEUTICALS INC shareholders